Roche Bids $4.8 Billion for Spark and Its Gene Therapy

(Bloomberg) -- Roche Holding AG’s $4.8 billion bid for Spark Therapeutics Inc. raises the stakes further in the bidding for makers of therapies that promise to treat rare, debilitating diseases by ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.